BNP Paribas Financial Markets’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,966
| Closed | -$167K | – | 4326 |
|
|
2022
Q1 | $167K | Sell |
5,966
-2,558
| -30% | -$70.1K | ﹤0.01% | 3189 |
|
|
2021
Q4 | $233K | Sell |
8,524
-4,321
| -34% | -$117K | ﹤0.01% | 3343 |
|
|
2021
Q3 | $349K | Buy |
12,845
+3,566
| +38% | +$88.2K | ﹤0.01% | 2879 |
|
|
2021
Q2 | $159K | Sell |
9,279
-3,774
| -29% | -$70.6K | ﹤0.01% | 2918 |
|
|
2021
Q1 | $273K | Sell |
13,053
-18,026
| -58% | -$416K | ﹤0.01% | 2900 |
|
|
2020
Q4 | $712K | Sell |
31,079
-1,365
| -4% | -$26K | ﹤0.01% | 2258 |
|
|
2020
Q3 | $529K | Buy |
32,444
+6,269
| +24% | +$114K | ﹤0.01% | 2187 |
|
|
2020
Q2 | $354K | Sell |
26,175
-8,370
| -24% | -$97.4K | ﹤0.01% | 2239 |
|
|
2020
Q1 | $409K | Buy |
34,545
+30,952
| +861% | +$686K | ﹤0.01% | 2457 |
|
|
2019
Q4 | $89.5K | Sell |
3,593
-1,203
| -25% | -$24.4K | ﹤0.01% | 3340 |
|
|
2019
Q3 | $81.6K | Buy |
4,796
+1,231
| +35% | +$22.4K | ﹤0.01% | 3223 |
|
|
2019
Q2 | $81.1K | Sell |
3,565
-2,667
| -43% | -$71.9K | ﹤0.01% | 3152 |
|
|
2019
Q1 | $200K | Buy |
6,232
+6,222
| +62,220% | +$193K | ﹤0.01% | 2702 |
|
|
2018
Q4 | $282 | Sell |
10
-949
| -99% | -$27.8K | ﹤0.01% | 4055 |
|
|
2018
Q3 | $27.6K | Hold |
959
| – | – | ﹤0.01% | 3287 |
|
|
2018
Q2 | $35.9K | Sell |
959
-46,893
| -98% | -$1.84M | ﹤0.01% | 3248 |
|
|
2018
Q1 | $1.88M | Buy |
47,852
+13
| +0% | +$475 | ﹤0.01% | 1414 |
|
|
2017
Q4 | $1.55M | Buy |
47,839
+45,146
| +1,676% | +$1.35M | ﹤0.01% | 1652 |
|
|
2017
Q3 | $83.9K | Sell |
2,693
-166
| -6% | -$4.91K | ﹤0.01% | 2879 |
|
|
2017
Q2 | $79.9K | Buy |
2,859
+2,713
| +1,858% | +$61.4K | ﹤0.01% | 2927 |
|
|
2017
Q1 | $2.5K | Sell |
146
-1,285
| -90% | -$18K | ﹤0.01% | 3479 |
|
|
2016
Q4 | $17.3K | Sell |
1,431
-363
| -20% | -$4.7K | ﹤0.01% | 3243 |
|
|
2016
Q3 | $28.4K | Buy |
1,794
+760
| +74% | +$11.4K | ﹤0.01% | 2701 |
|
|
2016
Q2 | $13.4K | Buy |
+1,034
| New | +$16.2K | ﹤0.01% | 2762 |
|
|
2016
Q1 | – | Sell |
-3,340
| Closed | -$75.2K | – | 3221 |
|
|
2015
Q4 | $75.2K | Sell |
3,340
-345
| -9% | -$6.82K | ﹤0.01% | 2521 |
|
|
2015
Q3 | $86.2K | Buy |
3,685
+2,138
| +138% | +$59K | ﹤0.01% | 2484 |
|
|
2015
Q2 | $44.3K | Buy |
1,547
+1,419
| +1,109% | +$37.2K | ﹤0.01% | 2566 |
|
|
2015
Q1 | $3.31K | Buy |
+128
| New | +$2.93K | ﹤0.01% | 3349 |
|
BNP Paribas Financial Markets's XENT Position: Q2 2022 in Review
BNP Paribas Financial Markets sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 5,966 shares — an estimated $167K sold.
BNP Paribas Financial Markets first reported a position in XENT in Q1 2015 and held it in 28 quarters. The position peaked at $1.88M in Q1 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- BNP Paribas Financial Markets reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 5,966 Intersect ENT, Inc shares in Q2 2022, an estimated $167K.
- BNP Paribas Financial Markets first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 28 quarters.
- BNP Paribas Financial Markets's Intersect ENT, Inc position peaked at $1.88M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2022, filed 12 Aug 2022.